Hvað þýðir "Hreinsa"?
Dýrið ber ekki stökkbreytinguna. Það mun ekki þróa sjúkdóminn og mun ekki gefa það áfram.
Hundur Hjartavöðvakvilli með barnadauða (CJM)
The Cardiomyopathy With Juvenile Mortality (CJM) DNA test in dogs is essential for early detection of this hereditary heart condition. CJM causes severe heart muscle disease leading to sudden death in young dogs, making genetic screening crucial for breeders and pet owners. By identifying carriers and affected dogs, the CJM DNA test helps prevent the spread of this fatal disorder within breeding lines. Early diagnosis through this test allows for better management and care of at-risk dogs. Reliable and accurate, the CJM DNA test supports responsible breeding practices and promotes healthier canine populations. Ensure your dog’s health and future by opting for the Cardiomyopathy With Juvenile Mortality DNA test today. Protect your pet with advanced genetic testing designed to save lives.
Skammstöfun: CJM
Grein stökkbreyting: YARS2 c.1054G>A
Erfðir: Autosomal víkjandi
Skammstöfun
CJM
Athuguð tíðni
Klínísk alvarleiki
Klínísk flokkun
Hjarta- og æðasjúkdómar
Greind stökkbreyting
YARS2 c.1054G>A
p.(E352K)
p.(E352K)
Erfðamáti
Autosomal víkjandi (Ljúkt)
Próf samantekt:
The DNA test for Cardiomyopathy With Juvenile Mortality (CJM) in dogs helps identify carriers of this genetic condition. CJM is a serious heart disease that can cause sudden death in young dogs. Early detection through testing allows breeders to make informed decisions and reduce the risk of passing the mutation to offspring. This test is especially important for breeds known to be affected by CJM. Responsible breeding based on DNA results promotes healthier future generations of dogs.
Fáanlegt úr pakkanum: Basic
Þetta DNA próf er innifalið frá pakkanum okkar Basic — og er líka hluti af pökkunum Basic, Standard, Advanced, Complete.
Skoða DNA prófunarpakka →Veldu pakkann sem passar best við ræktunar- eða heilsustefnu dýranna þinna.
Understanding Cardiomyopathy With Juvenile Mortality (CJM) in Dogs
Cardiomyopathy With Juvenile Mortality (CJM) is a serious and often fatal heart condition that primarily affects young dogs. It is characterized by the degeneration of heart muscle, leading to impaired heart function and, in severe cases, sudden cardiac death. CJM typically presents in dogs under the age of two, making early detection and intervention crucial for improving outcomes.
Pathophysiology of CJM
The underlying cause of CJM involves genetic mutations that disrupt the normal structure and function of cardiac muscle cells. As the disease progresses, the heart becomes progressively weaker, resulting in decreased cardiac output and potential rhythm disturbances. These changes can lead to symptoms such as lethargy, weakness, and exercise intolerance, which may rapidly escalate to life-threatening conditions.
Clinical Signs and Diagnosis
Dogs affected by CJM may exhibit a range of clinical signs, including coughing, difficulty breathing, and fainting episodes. Due to the rapid progression of the disease, it is essential for pet owners to seek veterinary attention promptly if they notice any concerning symptoms. Diagnosis typically involves a combination of physical examinations, echocardiography, and electrocardiograms to assess heart function and identify abnormalities.
Stjórnunar- og meðferðarúrræði
While there is currently no cure for CJM, management strategies aim to improve the quality of life and prolong survival for affected dogs. Treatment may include medications to support heart function, reduce fluid buildup, and manage arrhythmias. Additionally, lifestyle modifications, such as restricted exercise and regular veterinary check-ups, play an important role in managing the condition effectively.
Importance of Genetic Testing
Genetic testing for CJM is a valuable tool for identifying at-risk dogs and guiding breeding decisions. By understanding the genetic predisposition to this condition, breeders can make informed choices to reduce the incidence of CJM in future generations. Furthermore, early identification of affected individuals allows for timely intervention and better management of the disease.
Niðurstaða
Cardiomyopathy With Juvenile Mortality (CJM) represents a significant health concern in young dogs, emphasizing the importance of awareness, early detection, and genetic testing. By recognizing the signs of this condition and seeking appropriate veterinary care, pet owners can help ensure their dog's health and well-being. Ongoing research and advancements in genetic testing continue to provide hope for better management and prevention strategies for CJM.
Tegund viðurkennd fyrir prófið: Hjartavöðvakvilli með barnadauða (CJM)
- Belgian Malinois
- Belgian Sheepdog
- Belgian Shepherd Dog
- Lakenois
🧬 Interpretation of genotypes CJM
Arfgerð
Staða
🟡 N/N
Ekki flutningsaðili - Engin áhætta
🟡 N/CJM
Flutningsaðili - Engin áhætta
❌ CJM/CJM
Fyrir áhrifum - í hættu
Algengar spurningar: skilja túlkunina
Er „flutningsaðili“ alvara?
Nei. Dýrið er almennt heilbrigt en getur sent stökkbreytinguna til þess afkvæmi.
Hvað ef dýr hefur „áhrif“?
Það ber tvö stökkbreytt eintök. Búist er við klínískum einkennum eftir því sjúkdómnum. Það ætti ekki að rækta það.
Af hverju er munur á karli / konu?
Sumir sjúkdómar eru kyntengdir, þannig að tjáning þeirra er mismunandi eftir því kynlíf dýra.
Spáðu í afkvæmi
N/N (ekki-flutningsadili)
N/CJM (Flytjandi)
CJM/CJM (Fyrir áhrifum)
Algengar spurningar um DNA próf
Hvað greinir þetta DNA próf?
This DNA test detects the mutation associated with Cardiomyopathy With Juvenile Mortality (CJM) in order to identify clear, carrier, or at-risk animals.
Af hverju að prófa ræktunardýr?
DNA próf hjálpar ræktendum að skipuleggja öruggari pörun og draga úr hættu á að stökkbreytingin berist til afkvæma.
Hver er arfleifð þessa prófs?
Erfðastillingin sem tilkynnt er um fyrir þetta próf er Autosomal Recessive.
Hvaða stökkbreyting er greind í þessu prófi?
This test analyses the mutation YARS2 c.1054G>A.
Er burðardýr endilega fyrir áhrifum?
Ekki endilega. Túlkun fer eftir erfðamynstri og arfgerðinni sem myndast.
Heimildir
Gurtner Corinne, Hug Petra, Kleiter Miriam, Köhler Kernt, Dietschi Elisabeth, Jagannathan Vidhya, Leeb Tosso. YARS2 Missense Variant in Belgian Shepherd Dogs with Cardiomyopathy and Juvenile Mortality. Genes (Basel). 2020 Mar 14;11(3):313. doi: 10.3390/genes11030313.